Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P516: Adrenal suppression in inflammatory bowel disease patients treated with glucocorticoids: a systematic reviewECCO '17 Barcelona
Year: 2017
Authors:

Wood P.*1, Henderson P.1,2, Wilson D.1,2

1Royal Hospital For Sick Children, Department of Pediatric Gastroenterology, Edinburgh, United Kingdom 2University Of Edinburgh, Department of Child Life and Health, Edinburgh, United Kingdom

P517: Features of cytomegalovirus infection in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Makarchuk P., Belousova E., Volchkova E., Kudriavtseva E.

Moscow Regional Clinical Research Institute, Moscow, Russian Federation

P518: Remission induction in corticosteroid naïve children and adolescents with ulcerative colitis by adsorptive leucocytapheresis as monotherapy or in combination with low dose prednisolone after failure of first-line medicationsECCO '17 Barcelona
Year: 2017
Authors:

Tanaka T.*1, Goishi H.1, Kajihara T.1, Akagi M.1, Saniabadi A.2, Miura T.1

1Akitsu Hospital, Gastroenterology, Hiroshima, Japan 2JIMRO, Takasaki, Japan

P519: Anti-tumour necrosis-alpha therapy during pregnancy in patients with inflammatory bowel disease: safety in women and childrenECCO '17 Barcelona
Year: 2017
Authors:

Bernardes C., Loureiro R., Carvalho D., Borges V., Russo P., Saiote J., Ramos J.

Hospital de Sto Antόnio dos Capuchos, Gastroenterology, Lisbon, Portugal

P520: Perspective and self-efficacy of adolescents with inflammatory bowel disease post transition to adult careECCO '17 Barcelona
Year: 2017
Authors:

Yadav A., Forry M., O'Toole A., Patchett S.

Beaumont Hospital Dublin, Gastroenterology, Dublin, Ireland

P521: A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patientsECCO '17 Barcelona
Year: 2017
Authors:

Schulze H.*1, Esters P.1, Hartmann F.1, Stein J.2, Christ C.3, Zorn M.3, Dignass A.1

1Agaplesion Markus Hospital, Department of Medicine I, Frankfurt, Germany 2Interdisziplinäres Crohn Colitis Centrum, Frankfurt, Germany 3Immundiagnostik AG, Bensheim, Germany

P522: A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Coimbra A.*1, Rimola J.2, Cuatrecasas M.2, De Hertogh G.3, Van Assche G.3, Vanslembrouck R.3, Glerup H.4, Hedemann Nielsen A.4, Hagemann-Madsen R.4, Bouhnik Y.5, Zappa M.5, Cazals-Hatem D.5, D'Haens G.6, Stoker J.6, Meijer S.6, Rogler G.7, Boss A.7, Weber A.7, Zhao R.1, Keir M.1, Scherl A.1, deCrespigny A.1, Lu T.1, Panes J.2

1Genentech, Inc., South San Francisco, United States 2Hospital Clinic, Barcelona, Spain 3University Hospitals Leuven, Leuven, Belgium 4Regional Hospital Silkeborg, Silkeborg, Denmark 5Hospital Beaujon, Paris, France 6Academic Medical Center (AMC), Amsterdam, Netherlands 7University Hospital Zurich, Zurich, Switzerland

P523: Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohn's disease: a subanalysis of DIAMOND trialECCO '17 Barcelona
Year: 2017
Authors:

Motoya S.*1, Nakase H.2, Matsumoto T.3, Watanabe K.4, Hisamatsu T.5, Yoshimura N.6, Ishida T.7, Kato S.8, Nakagawa T.9, Nagahori M.10, Esaki M.11, Matsui T.12, Naito Y.13, Kanai T.14, Suzuki Y.15, Nojima M.16, Watanabe M.10, Hibi T.17 the DIAMOND Study Group

1Sapporo Kosei General Hospital, Inflammatory Bowel Disease Centre, Sapporo, Japan 2Sapporo Medical University School of Medicine, Department of Gastroenterology and Hepatology, Sapporo, Japan 3Iwate Medical University, Division of Gastroenterology, Department of Medicine, Morioka, Japan 4Osaka City General Hospital, Division of Gastroenterology, Osaka, Japan 5Kyorin University School of Medicine, Department of Internal Medicine, Tokyo, Japan 6Tokyo Yamate Medical Centre, Department of Medicine, Division of Gastroenterology, Tokyo, Japan 7Oita Red Cross Hospital, Department of Gastroenterology, Oita, Japan 8Saitama Medical University Saitama Medical Centre, Department of Gastroenterology and Hepatology, Kawagoe, Japan 9Chiba University School of Medicine, Department of Gastroenterology and Nephrology, Chiba, Japan 10Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan 11Kyushu University Graduate School of Medical Sciences, Department of Medicine and Clinical Science, Fukuoka, Japan 12Fukuoka University Chikushi Hospital, Department of Gastroenterology, Chikushino, Japan 13Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology, Kyoto, Japan 14Keio University School of Medicine, Department of Internal Medicine, Tokyo, Japan 15Toho University Sakura Medical Centre, Department of Internal Medicine, Sakura, Japan 16University of Tokyo, Centre for Translational Research, Institute of Medical Science Hospital, Tokyo, Japan 17Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan

P524: Long-term outcomes after restorative proctocolectomy and ileal pouch-anal anastomosis in children compared to adultsECCO '17 Barcelona
Year: 2017
Authors:

Diederen K.*1, Sahami S.2, Tabbers M.1, Benninga M.1, Kindermann A.1, Tanis P.2, Oomen M.3, Bemelman W.2, de Jong J.3

1Dept. of Pediatric Gastroenterology and Nutrition, Academic Medical Center, Amsterdam, Netherlands 2Dept. of Surgery, Academic Medical Center, Amsterdam, Netherlands 3Dept. of Pediatric Surgery, Academic Medical Center, Amsterdam, Netherlands

P525: Effectiveness and safety of vedolizumab in IBD patients: a multicentre experience of “real world data” from the UKECCO '17 Barcelona
Year: 2017
Authors:

Lenti M.V.*1, Levison S.2, Eliadou E.2, Willert R.2, Kemp K.2, Stansfield C.3, Assadsangabi A.3, Singh S.4, Crooks B.4, Tattersall S.4, Kenneth C.5, Subramanian S.6, Probert C.6, Smith P.7, Liu E.7, Limdi J.K.8, Hamlin P.J.1, Selinger C.P.1

1Leeds Teaching Hospitals, Leeds Gastroenterology Institute, Leeds, United Kingdom 2Manchester Royal Infirmary - Central Manchester University Hospitals, Department of Gastroenterology, Manchester, United Kingdom 3Salford Royal NHS Foundation Trust, Department of Gastroenterology, Salford, United Kingdom 4Royal Bolton Hospital, Department of Gastroenterology, Bolton, United Kingdom 5Bradford Royal Infirmary, Teaching Hospitals, Department of Gastroenterology, Bradford, United Kingdom 6Royal Liverpool University Hospital, Department of Gastroenterology, Liverpool, United Kingdom 7Wrightington, Wigan and Leigh NHS Trust, Thomas Linacre Centre, Wigan, United Kingdom 8Pennine Acute Hospitals NHS Trust, Department of Gastroenterology, Manchester, United Kingdom

P526: A prospective 52-week mucosal healing and deep remission assessment of small bowel and colonic Crohn's disease as detected by colon capsule endoscopyECCO '17 Barcelona
Year: 2017
Authors:

Oliva S.*1, Cohen S.2, Civitelli F.1, Aloi M.1, Viola F.1, Casciani E.3, Maccioni F.4, Hassan C.5, Papoff P.6, Cucchiara S.1

1Sapienza - University of Rome, Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Rome, Italy 2Children's Center for Digestive Health Care, Atlanta, United States 3Sapienza - University of Rome, Department of Emergency Radiology, Rome, Italy 4Sapienza - University of Rome, Department of Radiological Sciences, Oncology, and Pathology, Rome, Italy 5Nuovo Regina Margherita Hospital, Gastroenterology Department, Rome, Italy 6Sapienza - University of Rome, Department of Pediatrics PICU, Rome, Italy

P527: Infliximab biosimilar switching program overseen by specialist pharmacist saves money, realises investment and optimises therapyECCO '17 Barcelona
Year: 2017
Authors:

St. Clair Jones A.*1, Smith M.2

1Brighton and Sussex University Hospitals NHS Trust, Department of Pharmacy, Brighton, United Kingdom 2Brighton and Sussex University Hospitals NHS Trust, Department of Gastroenterology, Brighton, United Kingdom

P528: Long-term outcome of ulcerative colitis patients responders to cyclosporine in the biological eraECCO '17 Barcelona
Year: 2017
Authors:

Bastida G.*1,2, Sargalt L.3, Garcia V.4, Mesonero F.5, Braithwaite A.M.6, Montserrat A.7, Martín M.D.8, Sicilia B.9, Olivares D.10, Vicente R.11, Rodriguez E.12, Navarro P.13, Lobaton T.3

1La Fe University Hospital, Gastroenterology, Valencia, Spain 2CIBEREHD, barcelona, Spain 3Hospital Universitari Germans Trias i Pujol, Gastroenterology, Badalona (Barcelona), Spain 4Hospital Universitario Reina Sofía, Clinical Digestive Unit, Cόrdoba, Spain 5Hospital Ramon y Cajalbania, Gastroenterology & Hepatology, Madrid, Spain 6Hospital Universitario La Fe, Department of Gastroenterology, Valencia, Spain 7Corporaciό Sanitària Parc Taulí, Gastrotenterology, Sabadell, Spain 8Hospital Universitario La Paz, Department of Gastroenterology, Madrid, Spain 9Universitary Hospital of Burgos, Burgos, Spain 10Hospital Clínico San Carlos, Department of Gastroenterology, Madrid, Spain 11University Hospital Miguel Servet, Aparato Digestivo, Zaragoza, Spain 12Hospital La Candelaria, Digestive Service, Santa Cruz De Tenerife, Spain 13Hospital Clinico Universitario, Valencia, Spain

P529: Impact of stress in inflammatory bowel disease. Effect of a group psychological intervention programECCO '17 Barcelona
Year: 2017
Authors:

Bernabeu P.1, Buades N.1, Alonso M.1, Van-der Hofstadt C.1, Gutiérrez A.*2,3, Sempere L.2, Rodríguez-Marín J.1, Jover R.2

1Hospital General Universitario Alicante, Psychology Department, Alicante, Spain 2Hospital General Universitario Alicante, Department of Gastroenterology, Alicante, Spain 3CIBEREHD, Madrid, Spain

P530: Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-upECCO '17 Barcelona
Year: 2017
Authors:

Cassieri C.*1, Pica R.1, Avallone E.V.1, Brandimarte G.2, Zippi M.1, Crispino P.1, De Nitto D.1, Lecca G.2, Corrado C.1, Vernia P.1, Paoluzi P.1, Corazziari E.S.1

1“Sapienza” University, Department of Internal Medicine and Medical Specialties, Rome, Italy 2“Cristo Re” Hospital, Department of Internal Medicine, Rome, Italy

P531: Discontinuation of corticosteroids among Crohn's disease patients treated with vedolizumab in the United StatesECCO '17 Barcelona
Year: 2017
Authors:

Patel H.*1, Chastek B.2, Null K.D.3, Demuth D.4

1Immensity Consulting, Inc., Chicago, United States 2Optum, Eden Prairie, United States 3Takeda Pharmaceuticals U.S.A., Inc., Health Economics and Outcomes Research, Deerfield, United States 4Takeda Development Center Europe Ltd, Evidence and Value Generation, London, United Kingdom

P532: Biosimilar infliximab in anti-TNF naive inflammatory bowel disease patients – one-year clinical follow-upECCO '17 Barcelona
Year: 2017
Authors:

Kolar M.*1, Duricova D.1,2, Bortlik M.1,3, Hruba V.1, Machkova N.1, Mitrova K.1,4, Lukas M.1, Malickova K.5, Lukas M.1,5

1ISCARE I.V.F. a.s., IBD Clinical and Research Centre, Prague, Czech Republic 21st Medical Faculty, Charles University, Institute of Pharmacology, Prague, Czech Republic 3Military Hospital, Charles University, Department of Internal Medicine, Prague, Czech Republic 42nd Medical Faculty and Motol Hospital, Department of Paediatrics, Prague, Czech Republic 51st Medical Faculty and General Teaching Hospital, Charles University, Institute of Medical Biochemistry, Prague, Czech Republic

P533: Anaemia and iron deficiency in gastroenterology: a Scandinavian prospective, observational study of iron isomaltoside in clinical practiceECCO '17 Barcelona
Year: 2017
Authors:

Frigstad S.O.*1,2,3, Hammarlund P.4, Bonderup O.5, Rannem T.6, Haaber A.7, Fallingborg J.8, Blom H.9, Bajor A.10,11, Hellström P.M.12

1Vestre Viken Hospital Trust, Department of Medicine Baerum Hospital, Drammen, Norway 2Østfold Hospital Trust, Department of Research, Grålum, Norway 3University of Oslo, Institute of Clinical Medicine, Oslo, Norway 4Angelholms Hospital, Department of Medicine, Angelholm, Sweden 5Silkeborg Regional Hospital, Department of Gastroenterology, Silkeborg, Denmark 6Nordsjaelland Hospital, Department of gastroenterology, Hilleroed, Denmark 7Herlev-Gentofte Hospital, Department of Gastroenterology, Hellerup, Denmark 8Aalborg University Hospital, Department of Medical Gastroenterology, Aalborg, Denmark 9Sunderby Hospital, Department of Medicine, Luleå, Sweden 10Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg, Sweden 11SÄS, Department of Medicine, Borås, Sweden 12Uppsala University Hospital, Department of Medical Sciences, Uppsala, Sweden

P534: Illness perception in IBD patients: a prospective studyECCO '17 Barcelona
Year: 2017
Authors:

Vegni E.1, Gilardi D.2, Corrò B.E.3, Menichetti J.4, Bonovas S.5, Leone D.1, Allocca M.2, Furfaro F.2, Danese S.2,6, Fiorino G.*7

1University of Milan, Department of Health Sciences, Milan, Italy 2Humanitas Research Hospital, IBD Center, Gastroenterology, Rozzano, Milan, Italy 3University of Milan, Milan, Italy 4Catholic University, Department of Psychology, Milan, Italy 5Humanitas Research Hospital, Department of Gastroenterology, IBD Center, Rozzano, Italy 6Humanitas University, Biomedical Sciences, Rozzano, Milan, Italy 7Humanitas Clinical and Research Center, IBD Center, Department of Gastroenterology, Rozzano, Italy

P535: Outcomes of endoscopic resections of large non-polypoid lesions inflammatory bowel disease: a single United Kingdom centre experienceECCO '17 Barcelona
Year: 2017
Authors:

Gulati S., Emmanuel A., Burt M., Hayee B., Haji A.

King's College Hospital, King's Institute of Therapeutic Endoscopy, London, United Kingdom